Skip to content

Generate Biomedicines, Inc. GENB Operating Lease Liabilities

Operating Lease Liabilities at other companies

MYR Group logo
MYR GroupMYRG
$37.6M+24.7%
Repligen logo
RepligenRGEN
$119.96M-13.7%
LKQ logo
LKQLKQ
$1.14B-5.4%
AppFolio logo
AppFolioAPPF
$31.98M-12.0%
CHE
ChemedCHE
$104.45M+2.3%
Boyd Gaming logo
Boyd GamingBYD
$536.75M-10.3%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's operating lease liabilities?
Generate Biomedicines, Inc. (GENB) reported operating lease liabilities of $49.09M in Q1 2026.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.